AKAP4 and ovarian carcinoma: In addition, AKAP4 is a novel CTA that is abnormally expressed in multiple types of malignant tumors, including ovarian cancer [14], cervical cancer [15], multiple myeloma [16], breast cancer [17], and prostate cancer [18].